Proteomic Methods Diagnose Pancreatic Cancer
By LabMedica International staff writers Posted on 08 Apr 2014 |

Image: The LTQ-FT Orbitrap XL Hybrid Ion Trap Mass Spectrometer (Photo courtesy of Thermo Scientific).
A method has been developed that identifies pancreatic cancer's visible precursors with 97% certainty, and is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery.
The poor prognosis for pancreatic cancer, is due to the fact that the tumors often develop unnoticed, and rarely causes symptoms until they have spread to other organs, however fluid-filled compartments in the pancreas, called cysts, may be precursors of the cancer.
Scientists at the Sahlgrenska University Hospital (Gothenburg, Sweden) evaluated whether cyst fluid mucin expression could predict malignant potential and/or transformation in pancreatic cystic lesions (PCLs). A proteomic method was devised and prospectively evaluated in consecutive patients referred to a tertiary center for endoscopic ultrasound-guided aspiration of cystic lesions from May 2007 through November 2008 (discovery cohort) and from December 2008 through October 2012 (validation cohort).
Cytology and cyst fluid carcinoembryonic antigen (CEA; premalignancy greater than 192 ng/mL, malignancy greater than 1,000 ng/mL) were routinely analyzed. Samples were further processed as follows: one-dimensional gel electrophoresis, excision of high-mass areas, tryptic digestion and nanoliquid chromatography–tandem mass spectrometry, with peptide identification. Peptides were separated on a reversed column coupled to a hybrid linear ion trap-Fourier transform ion cyclotron resonance mass spectrometry instrument equipped with a 7-tesla magnet (LTQ-FT; Thermo Electron; Bremen, Germany).
Proteomic mucin profiling proved statistically significantly more accurate at 97.5%; than cytology at 71.4%, and cyst fluid CEA at 78.0% in identifying the 37/79 (46.8%) lesions with malignant potential, either premalignant or malignant tumors. The accuracy of proteomics was nearly identical, 96.6% versus 98.0%, between the 29 patients in the discovery and 50 patients in the validation cohorts. Furthermore, mucin profiling predicted malignant transformation, present in 16/29 lesions with available histology, with 89.7% accuracy.
Karolina Sjöberg Jabbar, MD, the corresponding author of the study said, “This is an exceptionally good result for a diagnostic test, and we are very hopeful that the method will enable more instances of early discovery of pancreatic cancer, at a stage when the cancer can be treated or prevented. This approach may also minimize the risk of unnecessary operations on nonmalignant cysts.” The study was published in the March 2014 issue of the Journal of the National Cancer Institute.
Related Links:
Sahlgrenska University Hospital
Thermo Electron
The poor prognosis for pancreatic cancer, is due to the fact that the tumors often develop unnoticed, and rarely causes symptoms until they have spread to other organs, however fluid-filled compartments in the pancreas, called cysts, may be precursors of the cancer.
Scientists at the Sahlgrenska University Hospital (Gothenburg, Sweden) evaluated whether cyst fluid mucin expression could predict malignant potential and/or transformation in pancreatic cystic lesions (PCLs). A proteomic method was devised and prospectively evaluated in consecutive patients referred to a tertiary center for endoscopic ultrasound-guided aspiration of cystic lesions from May 2007 through November 2008 (discovery cohort) and from December 2008 through October 2012 (validation cohort).
Cytology and cyst fluid carcinoembryonic antigen (CEA; premalignancy greater than 192 ng/mL, malignancy greater than 1,000 ng/mL) were routinely analyzed. Samples were further processed as follows: one-dimensional gel electrophoresis, excision of high-mass areas, tryptic digestion and nanoliquid chromatography–tandem mass spectrometry, with peptide identification. Peptides were separated on a reversed column coupled to a hybrid linear ion trap-Fourier transform ion cyclotron resonance mass spectrometry instrument equipped with a 7-tesla magnet (LTQ-FT; Thermo Electron; Bremen, Germany).
Proteomic mucin profiling proved statistically significantly more accurate at 97.5%; than cytology at 71.4%, and cyst fluid CEA at 78.0% in identifying the 37/79 (46.8%) lesions with malignant potential, either premalignant or malignant tumors. The accuracy of proteomics was nearly identical, 96.6% versus 98.0%, between the 29 patients in the discovery and 50 patients in the validation cohorts. Furthermore, mucin profiling predicted malignant transformation, present in 16/29 lesions with available histology, with 89.7% accuracy.
Karolina Sjöberg Jabbar, MD, the corresponding author of the study said, “This is an exceptionally good result for a diagnostic test, and we are very hopeful that the method will enable more instances of early discovery of pancreatic cancer, at a stage when the cancer can be treated or prevented. This approach may also minimize the risk of unnecessary operations on nonmalignant cysts.” The study was published in the March 2014 issue of the Journal of the National Cancer Institute.
Related Links:
Sahlgrenska University Hospital
Thermo Electron
Latest Pathology News
- New Laser-Based Method to Accelerate Cancer Diagnosis
- New AI Model Predicts Gene Variants’ Effects on Specific Diseases
- Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
- Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples
- 3D Cell Culture System Could Revolutionize Cancer Diagnostics
- Painless Technique Measures Glucose Concentrations in Solution and Tissue Via Sound Waves
- Skin-Based Test to Improve Diagnosis of Rare, Debilitating Neurodegenerative Disease
- Serum Uromodulin Could Indicate Acute Kidney Injury in COVID-19 Patients
- AI Model Reveals True Biological Age From Five Drops of Blood
- First-Of-Its-Kind AI Tool Visualizes Cell’s ‘Social Network’ To Treat Cancer
- New Test Diagnoses High-Risk Childhood Brain Tumors
- Informatics Solution Elevates Laboratory Efficiency and Patient Care
- Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
- New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
- New Technique Predicts Aggressive Tumors Before They Metastasize
- Butterfly Wings-Inspired Imaging Technique Enables Faster Cancer Diagnosis
Channels
Molecular Diagnostics
view channel
Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more
Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
Approximately one in three women aged 14-49 in the United States will experience bacterial vaginosis (BV), a vaginal bacterial imbalance, at some point in their lives. Around 50% of BV cases do not present... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
Royal Philips (Amsterdam, The Netherlands) has expanded its partnership with Ibex Medical Analytics (Tel Aviv, Israel) and released the new Philips IntelliSite Pathology Solution (PIPS) to further accelerate... Read more
Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
Grifols (Barcelona, Spain), a manufacturer of plasma-derived medicines and innovative diagnostic solutions, has entered into a strategic agreement with Inpeco (Novazzano, Switzerland), a global leader... Read more